Search

Search Constraints

You searched for: Author/Creator De Prijck, Bernard

Search Results

2. Addition of elotuzumab to lenalidomide and dexamethasone for patients with newly diagnosed, transplantation ineligible multiple myeloma (ELOQUENT-1): an open-label, multicentre, randomised, phase 3 trial. Issue 6 (June 2022)

3. Angioimmunoblastic T-Cell Lymphoma and Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma: A Novel Form of Composite Lymphoma Potentially Mimicking Richter Syndrome. (June 2021)

4. Darbepoetin‐alfa and intravenous iron administration after autologous hematopoietic stem cell transplantation: A prospective multicenter randomized trial. Issue 12 (30th September 2013)

5. Diagnosis and follow-up of monoclonal gammopathies of undetermined significance; information for referring physicians. (September 2013)

6. Dual‐tracer PET/CT scan after injection of combined [18F]NaF and [18F]FDG outperforms MRI in the detection of myeloma lesions. Issue 2 (28th March 2019)

8. Long‐term safety follow‐up of a randomized trial of darbepoetin alpha and intravenous iron following autologous hematopoietic cell transplantation. Issue 7 (July 2015)